PCN45 COST COMPARISON BETWEEN 90Y IBRITUMOMAB TIUXETAN CONSOLIDATION AND RITUXIMAB MAINTENANCE POST-CHEMOTHERAPY IN NAS LYMPHOMA IN SPAIN
Abstract
Authors
JF Tomas L Febrer C Piol E Musi
JF Tomas L Febrer C Piol E Musi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now